Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study.
Publication
, Conference
Bini, EJ; Aytaman, A; Anand, BS; Samanta, A; Nemchausky, B; Trevino, HH; Mah'moud, MA; Weston, AP; Pimstone, NR; Stancic, S; Chang, KM ...
Published in: HEPATOLOGY
October 1, 2002
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2002
Volume
36
Issue
4
Start / End Page
581A / 581A
Location
BOSTON, MASSACHUSETTS
Publisher
W B SAUNDERS CO
Conference Name
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Bini, E. J., Aytaman, A., Anand, B. S., Samanta, A., Nemchausky, B., Trevino, H. H., … Mannix-James, R. (2002). Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study. In HEPATOLOGY (Vol. 36, pp. 581A-581A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
Bini, E. J., A. Aytaman, B. S. Anand, A. Samanta, B. Nemchausky, H. H. Trevino, M. A. Mah’moud, et al. “Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study.” In HEPATOLOGY, 36:581A-581A. W B SAUNDERS CO, 2002.
Bini EJ, Aytaman A, Anand BS, Samanta A, Nemchausky B, Trevino HH, et al. Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study. In: HEPATOLOGY. W B SAUNDERS CO; 2002. p. 581A-581A.
Bini, E. J., et al. “Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study.” HEPATOLOGY, vol. 36, no. 4, W B SAUNDERS CO, 2002, pp. 581A-581A.
Bini EJ, Aytaman A, Anand BS, Samanta A, Nemchausky B, Trevino HH, Mah’moud MA, Weston AP, Pimstone NR, Stancic S, Chang KM, Mannix-James R. Randomized comparison of daily interferon alfa-2b and ribavirin for 24 weeks versus standard combination therapy for 48 weeks in veterans with chronic hepatitis C: Final results of a va multicenter study. HEPATOLOGY. W B SAUNDERS CO; 2002. p. 581A-581A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2002
Volume
36
Issue
4
Start / End Page
581A / 581A
Location
BOSTON, MASSACHUSETTS
Publisher
W B SAUNDERS CO
Conference Name
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics